DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Monday reported a loss of $8.1 million in its fourth quarter.
The Devon, Pennsylvania-based company said it had a loss of 60 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.
For the year, the company reported that its loss widened to $32 million, or $2.48 per share.
Zynerba shares have declined 27 percent since the beginning of the year. The stock has decreased 55 percent in the last 12 months.